Here’s why the Telix (ASX:TLX) share price is crashing 14% lower

This high flying biotech is having an off-day…

| More on:
white arrow dropping down

Image source: Getty Images

The Telix Pharmaceuticals Ltd (ASX: TLX) share price has been among the worst performers on the All Ordinaries on Monday.

The biopharmaceutical company’s shares were down as much as 14% to $5.53 at one stage.

Despite this, the Telix share price is still up more than 300% over the last 12 months.

Why is the Telix share price crashing today?

The weakness in the Telix share price on Monday appears to be due to a combination of broad market weakness, profit taking, and slight concerns over a study update this morning.

In respect to the latter, this morning Telix released an update on its study of TLX101 in combination with external beam radiation therapy in recurrent glioblastoma multiforme.

According to the release, Telix has decided to cease recruitment after dosing a tenth patient in this recurrent disease (second line) treatment setting. This was well short of its original recruitment target.

Nevertheless, the company has been pleased with the interim analysis of safety and preliminary efficacy. It feels the data is sufficiently encouraging to warrant study in front-line therapy, where radiation therapy is more extensively used.

What is TLX101?

TLX101 is currently under evaluation for the treatment of recurrent glioblastoma multiforme at five sites across Australia and Europe. Recurrent glioblastoma is a highly aggressive cancer that progresses rapidly and has very few effective treatment options.

Telix’s Chief Medical Officer, Dr. Colin Hayward, commented: “We are highly encouraged by the safety profile of this single arm dose-escalation study, where different dosing regimens have been combined with external radiation therapy.”

“Whilst a small study of ten patients, promising overall survival and anti-tumour response observed from longitudinal imaging supports the decision to progress this candidate into an earlier line of therapy. A follow-on study is currently in planning to accelerate the development of TLX101 in this important therapy area with high unmet medical need,” he added.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of January 12th 2022

James Mickleboro owns Telix shares. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Fallers

asx share price falling lower represented by investor wearing paper bag on head with sad face
Share Fallers

These were the worst performing ASX 200 shares last week

It was another tough week for the S&P/ASX 200 Index (ASX: XJO) after the US Federal Reserve indicated that it would start …

Read more »

share price dropping
Share Fallers

Why AnteoTech, Newcrest, Nitro, and ResMed shares are falling

In late trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week with on a positive note. …

Read more »

Young boy with glasses and grey long sleeved top looking pensive as if wondering about asx share price
Share Fallers

The OZ Minerals (ASX:OZL) share price has dumped 11% this week. Is it a bargain?

Key points OZ Minerals shares are down 11% so far since last Friday’s close Despite the bearishness, the team at …

Read more »

share price dropping
Share Fallers

Why Evolution, Cettire, Hipages, and Kogan shares are sinking

After a decent start to the day, the S&P/ASX 200 Index (ASX: XJO) is tumbling lower again in afternoon trade. At …

Read more »

a man in a hard hat and checkered shirt holds paperwork in one hand as he holds his hands upwards in an enquiring manner as though asking a question or exasperated by uncertainty.
Share Fallers

OZ Minerals (ASX:OZL) share price slips despite record $2 billion revenue

The OZ Minerals Ltd (ASX: OZL) share price is sliding during this morning’s session and is now trading 1.48% in the …

Read more »

A man in a white coat holds a laptop in one hand and his head in the other, it's bad news.
Share Fallers

Polynovo (ASX:PNV) share price melts 31% in 2 weeks. What’s going on?

Key points The Polynovo share price has slipped more than 30% in the past 2 weeks Pressure has been on …

Read more »

An arrow crashes through the ground as a businessman watches on.
Share Fallers

Why Accent, BrainChip, Fortescue, and Novonix shares are sinking

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on track to record a big decline. At the time of …

Read more »

A guys points his fingers down.
Share Fallers

Why Adairs, Bigtincan, Regis Resources, and Telix shares are sinking

In afternoon trade on Monday, the S&P/ASX 200 Index (ASX: XJO) is on course to start the week with a decline. …

Read more »